These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 19446744

  • 41. Intracranial ependymomas in children: society of pediatric oncology experience with postoperative hyperfractionated local radiotherapy.
    Conter C, Carrie C, Bernier V, Geoffray A, Pagnier A, Gentet JC, Lellouch-Tubiana A, Chabaud S, Frappaz D.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1536-42. PubMed ID: 19362789
    [Abstract] [Full Text] [Related]

  • 42. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
    Ebert C, von Haken M, Meyer-Puttlitz B, Wiestler OD, Reifenberger G, Pietsch T, von Deimling A.
    Am J Pathol; 1999 Aug 01; 155(2):627-32. PubMed ID: 10433955
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocellular carcinoma.
    Wang G, Zhao Y, Liu X, Wang L, Wu C, Zhang W, Liu W, Zhang P, Cong W, Zhu Y, Zhang L, Chen S, Wan D, Zhao X, Huang W, Gu J.
    Genes Chromosomes Cancer; 2001 Jul 01; 31(3):221-7. PubMed ID: 11391792
    [Abstract] [Full Text] [Related]

  • 45. Allelic imbalance on chromosome 10 in rat endometrial adenocarcinomas.
    Nordlander C, Behboudi A, Levan G, Levan KK.
    Cancer Genet Cytogenet; 2005 Jan 15; 156(2):158-66. PubMed ID: 15642397
    [Abstract] [Full Text] [Related]

  • 46. High frequency of chromosome 14 deletion in early-onset colon cancer.
    Mourra N, Zeitoun G, Buecher B, Finetti P, Lagarde A, Adelaide J, Birnbaum D, Thomas G, Olschwang S.
    Dis Colon Rectum; 2007 Nov 15; 50(11):1881-6. PubMed ID: 17726634
    [Abstract] [Full Text] [Related]

  • 47. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.
    Lukashova-v Zangen I, Kneitz S, Monoranu CM, Rutkowski S, Hinkes B, Vince GH, Huang B, Roggendorf W.
    Acta Neuropathol; 2007 Mar 15; 113(3):325-37. PubMed ID: 17265049
    [Abstract] [Full Text] [Related]

  • 48. Ependymal tumors with sarcomatous change ("ependymosarcoma"): a clinicopathologic and molecular cytogenetic study.
    Rodriguez FJ, Scheithauer BW, Perry A, Oliveira AM, Jenkins RB, Oviedo A, Mork SJ, Palmer CA, Burger PC.
    Am J Surg Pathol; 2008 May 15; 32(5):699-709. PubMed ID: 18347506
    [Abstract] [Full Text] [Related]

  • 49. Thymidylate synthetase allelic imbalance in clear cell renal carcinoma.
    Colavito D, Cartei G, Dal Bianco M, Stecca A, Zustovich F, Dalle Carbonare M, Ragazzi E, Farina M, Colombrino E, Leon A.
    Cancer Chemother Pharmacol; 2009 Nov 15; 64(6):1195-200. PubMed ID: 19306093
    [Abstract] [Full Text] [Related]

  • 50. Genomic characterization of ependymomas reveals 6q loss as the most common aberration.
    Olsen TK, Gorunova L, Meling TR, Micci F, Scheie D, Due-Tønnessen B, Heim S, Brandal P.
    Oncol Rep; 2014 Aug 15; 32(2):483-90. PubMed ID: 24939246
    [Abstract] [Full Text] [Related]

  • 51. Molecular alterations at 9q33.1 and polyploidy in asbestos-related lung cancer.
    Nymark P, Kettunen E, Aavikko M, Ruosaari S, Kuosma E, Vanhala E, Salmenkivi K, Pirinen R, Karjalainen A, Knuutila S, Wikman H, Anttila S.
    Clin Cancer Res; 2009 Jan 15; 15(2):468-75. PubMed ID: 19147751
    [Abstract] [Full Text] [Related]

  • 52. Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization.
    Scheil S, Brüderlein S, Eicker M, Herms J, Herold-Mende C, Steiner HH, Barth TF, Möller P.
    Brain Pathol; 2001 Apr 15; 11(2):133-43. PubMed ID: 11303789
    [Abstract] [Full Text] [Related]

  • 53. Chromosome aberrations in four ependymomas.
    Sawyer JR, Sammartino G, Husain M, Boop FA, Chadduck WM.
    Cancer Genet Cytogenet; 1994 Jun 15; 74(2):132-8. PubMed ID: 8019957
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray.
    Ammerlaan AC, de Bustos C, Ararou A, Buckley PG, Mantripragada KK, Verstegen MJ, Hulsebos TJ, Dumanski JP.
    Genes Chromosomes Cancer; 2005 Aug 15; 43(4):329-38. PubMed ID: 15880457
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Loss of chromosome 22 and proliferative potential in ependymomas.
    Debiec-Rychter M, Biernat W, Zakrzewski K, Krul W, Liberski PP.
    Folia Neuropathol; 2003 Aug 15; 41(4):191-5. PubMed ID: 14977248
    [Abstract] [Full Text] [Related]

  • 58. Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis.
    de Bont JM, den Boer ML, Kros JM, Passier MM, Reddingius RE, Smitt PA, Luider TM, Pieters R.
    J Neuropathol Exp Neurol; 2007 Jun 15; 66(6):505-16. PubMed ID: 17549010
    [Abstract] [Full Text] [Related]

  • 59. Gene aberrations in childhood brain tumors.
    Kucerová H, Stejskalová E, Vícha A, Tichý M, Chánová M, Sumerauer D, Koutechký J, Eckschlager T.
    Folia Biol (Praha); 2000 Jun 15; 46(5):187-90. PubMed ID: 11055797
    [Abstract] [Full Text] [Related]

  • 60. Current and evolving knowledge of prognostic factors for pediatric ependymomas.
    Andreiuolo F, Ferreira C, Puget S, Grill J.
    Future Oncol; 2013 Feb 15; 9(2):183-91. PubMed ID: 23414469
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.